৳ 85/unit
Pack: ৳ 850
৳ 85/unit
Pack: ৳ 850
At a glance
Pidotimod is an immunostimulant that boosts the immune system in immunodeficiency conditions predisposing individuals to frequent infections, especially respiratory tract infections. It is indicated for recurrent upper and lower respiratory tract infections in children and adults, acute respiratory tract infections, asthma, COPD, chronic bronchitis, rhinitis, sinusitis, pneumonia, and immunological disorders.
Indications
- Recurrent upper and lower respiratory tract infections in children and adults
- Acute respiratory tract infections
- Asthma
- Chronic Obstructive Pulmonary Disorder (COPD)
- Chronic bronchitis
- Rhinitis, sinusitis
- Pneumonia
- Immunological disorders
Pharmacology
Pidotimod reinforces and stimulates both humoral immunity and T-lymphocyte-mediated cellular immunity. It stimulates macrophage migration, enhancing phagocytosis and elimination of infectious germs. It has prophylactic and protective action against Gram-positive and Gram-negative germs without intrinsic antimicrobial properties.
Dosage
Acute Phase:
- Adults: 2 tablets (400 mg) or 1 tablet (800 mg), twice daily, for 15 days
- Elderly and children: 1 tablet (400 mg), twice daily, for 15 days
Prophylactic Phase:
- Adults: 2 tablets (400 mg) or 1 tablet (800 mg), once daily, for 60 days
- Elderly and children: 1 tablet (400 mg), once daily, for 60 days
Side effects
Side Effects:
- Diarrhea (rare)
- At high doses: Sedation, ataxia, dyspnea, cyanosis
Use in pregnancy
Use in Pregnancy: No adequate studies in pregnant women; not recommended during first trimester; use based on risk-benefit factor.
Pregnancy Category: B — always consult a doctor before taking during pregnancy.
Precautions & warnings
- Do not use concurrently with immunosuppressive treatment
- Inform doctor if you have kidney disease or diabetes
- Caution during pregnancy and lactation
- Avoid alcohol consumption
Overdose effects
No clinical data on overdose; in animal data, slight sedation, ataxia, dyspnea, cyanosis (resolved within 24 hours); treatment: gastric lavage, activated charcoal, supportive measures.
Storage conditions
Store below 30°C in a dry place, away from light; keep out of reach of children.